🔗 Share this article

The prestigious award in medical science has been awarded for transformative findings that illuminate how the body's defense network targets harmful pathogens while sparing the healthy tissues.

A trio of esteemed researchers—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—share this honor.

Their work identified specialized "security guards" within the defense system that remove rogue immune cells capable of harming the organism.

These discoveries are now enabling new treatments for autoimmune diseases and cancer.

The laureates will share a monetary award worth 11 million Swedish kronor.

Crucial Findings

"Their work has been essential for comprehending how the immune system functions and the reason we don't all develop severe autoimmune diseases," commented the chair of the award panel.

This trio's research address a core mystery: How does the immune system protect us from countless infections while keeping our healthy cells intact?

The body's protection system uses immune cells that scan for signs of disease, including viruses and germs it has not met before.

These defenders utilize detectors—called receptors—that are produced by chance in countless combinations.

That gives the defense network the ability to fight a broad range of threats, but the unpredictability of the process unavoidably creates white blood cells that may attack the host.

Security Guards of the Immune System

Researchers previously knew that a portion of these harmful defense cells were destroyed in the thymus—the site where immune cells mature.

The latest Nobel Prize honors the identification of T-reg cells—described as the immune system's "peacekeepers"—which patrol the system to disarm other defenders that assault the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "The findings have established a novel area of investigation and accelerated the development of innovative therapies, for instance for tumors and autoimmune diseases."

In malignancies, regulatory T-cells prevent the body from fighting the growth, so studies are aimed at lowering their quantity.

In self-attack disorders, experiments are exploring boosting T-reg cells so the body is not being harmed. A similar method could also be effective in minimizing the risks of transplanted organ rejection.

Pioneering Studies

Prof Sakaguchi, of a Japanese institution, performed experiments on mice that had their thymus extracted, causing self-attack conditions.

The researcher demonstrated that introducing immune cells from other animals could stop the disease—suggesting there was a system for preventing immune cells from attacking the body.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were studying an inherited immune disorder in mice and humans that led to the identification of a gene critical for how regulatory T-cells function.

"Their groundbreaking work has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally attacking the body's own tissues," commented a leading biological science specialist.

"This research is a striking example of how basic physiological research can have far-reaching consequences for human health."